Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 39
Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment
Pingping Feng, Xinyang Hu, Sining Zhou, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Post-pandemic insights on COVID-19 and premature ovarian insufficiency
Yaguang Han, Yang Dai, Kexin Wang, et al.
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access
Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial
Mohammad Reza Aghasadeghi, Mohammad Ali Zaheri Birgani, Saeedreza Jamalimoghadamsiyahkali, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
Aliakbar Hasankhani, Abolfazl Bahrami, Bahareh Tavakoli‐Far, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Immune cell-derived extracellular vesicles for precision therapy of inflammatory-related diseases
Shuo Li, Wenqing Li, Xianggui Wu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 533-547
Closed Access | Times Cited: 3
Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a mechanistic review
Ibrahim Jantan, Nor Azrina Norahmad, Yuandani Yuandani, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-26
Closed Access | Times Cited: 3
Cytokine Levels and Severity of Illness Scoring Systems to Predict Mortality in COVID-19 Infection
Sevda Onuk, Hilal Sipahioğlu, Samet Karahan, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 387-387
Open Access | Times Cited: 11
Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric Metabolomics
Mélanie Bourgin, Sylvère Durand, Guido Kroemer
Metabolites (2023) Vol. 13, Iss. 3, pp. 342-342
Open Access | Times Cited: 8
In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19
Somayeh Hashemi Sheikhshabani, Zeinab Amini‐Farsani, Parastoo Modarres, et al.
Human Gene (2023) Vol. 36, pp. 201172-201172
Open Access | Times Cited: 8
Musculoskeletal and neuromuscular dysfunction due to covid-19 infection: A review
Vivek Chauhan, Akash Pandey, Adrija Rakshit, et al.
Vacunas (2024) Vol. 25, Iss. 3, pp. 355-366
Closed Access | Times Cited: 2
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 2
Long-Term Functional Limitations and Predictors of Recovery after COVID-19: A Multicenter Prospective Cohort Study
Marla K. Beauchamp, Renata Noce Kirkwood, MyLinh Duong, et al.
The American Journal of Medicine (2024)
Open Access | Times Cited: 2
Interplay of host and viral factors in inflammatory pathway mediated cytokine storm during RNA virus infection
Riya Chaudhary, Aparna Meher, Pandikannan Krishnamoorthy, et al.
Current Research in Immunology (2023) Vol. 4, pp. 100062-100062
Open Access | Times Cited: 7
Role of the Renin-Angiotensin System in Long COVID’s Cardiovascular Injuries
Elena Cojocaru, Cristian Cojocaru, Cristiana-Elena Vlad, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2004-2004
Open Access | Times Cited: 7
A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants
Yidan Dong, Wei Zhai, Bangjiang Fang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal
Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 450-450
Open Access | Times Cited: 1
Effect of JAK Inhibitors on the Risk of Death in Patients with Moderate to Severe COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
The Canadian Journal of Hospital Pharmacy (2024) Vol. 77, Iss. 2
Closed Access | Times Cited: 1
Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19
Samantha C. Karunarathna, Wenhua Lu, Nimesha Patabedige, et al.
New Zealand Journal of Botany (2024), pp. 1-59
Closed Access | Times Cited: 1
Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit
Sandrelli Meridiana de Fátima Ramos dos Santos Medeiros, Bruna Maria Nepomuceno Sousa Lino, Vinícius Pietta Perez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Tannic acid modulates SARS-CoV-2 pathogenesis by curbing key host receptors and oxidative stress
Augustus Akshaya Rani, Yashwanth Radhakrishnan, James Prabhanand Bhaskar, et al.
Toxicology in Vitro (2024), pp. 105971-105971
Closed Access | Times Cited: 1
Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury
Gehui Sun, Bin Wang, Hongquan Zhu, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Exogenous Klotho Extends Survival in COVID-19 Model Mice
Farhang Alem, Natalia Campos‐Obando, Aarthi Narayanan, et al.
Pathogens (2023) Vol. 12, Iss. 12, pp. 1404-1404
Open Access | Times Cited: 3
Results of a 12-week open-label, non-interventional study of the efficacy and safety of olokizumab therapy in patients with rheumatoid arthritis after switching from anti-B-cell therapy during the SARS-CoV-2 pandemic
A. A. Akimova, N. E. Banshchikova, А. Э. Сизиков, et al.
Rheumatology Science and Practice (2023) Vol. 61, Iss. 1, pp. 25-33
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top